Papillary Renal Cell Carcinoma

• CLINICAL_TRIALS trial_result · 2025-09-22
  Clinical Trial Update: A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma [Phase 2]

  Phase 2 study of nivolumab in combination with cabozantinib in patients with non-clear cell renal cell carcinoma; the trial is currently act…

• CLINICAL_TRIALS trial_result · 2024-11-01
  Clinical Trial Update: A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology [Phase 1]

  Phase 1 study assessing safety, pharmacokinetics, and preliminary effectiveness of AGS-16C3F as monotherapy in renal cell carcinoma with cle…

• CLINICAL_TRIALS trial_result · 2023-12-11
  Clinical Trial Update: CREATE: Cross-tumoral Phase 2 With Crizotinib [Phase 2]

  Phase 2 cross-tumor trial evaluating crizotinib in multiple locally advanced or metastatic cancers; study completed.

• CLINICAL_TRIALS trial_result · 2023-11-29
  Clinical Trial Update: Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy [Phase 3]

  Phase 3 clinical trial evaluating a multi-classifier system to stratify stage III papillary renal cell carcinoma in the adjuvant therapy set…

• CLINICAL_TRIALS trial_result · 2023-03-21
  Clinical Trial Update: A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer [Phase 2]

  Phase 2 study of the MET kinase inhibitor INC280 (epernestib) in papillary renal cell cancer has completed with results posted.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2022-09-06
  Clinical Trial Update: Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma [Phase 2]

  Phase 2 clinical trial update evaluating axitinib as first-line treatment for advanced or metastatic papillary renal cell carcinoma.

• CLINICAL_TRIALS trial_result · 2022-09-02
  Clinical Trial Update: Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed [Phase 2]

  A Phase 2 trial update reports results from testing cabozantinib, crizotinib, savolitinib, and sunitinib in patients with locally advanced o…

• CLINICAL_TRIALS trial_result · 2021-01-26
  Clinical Trial Update: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma [Phase 1, Phase 2]

  A Phase 1/2 trial studying vandetanib combined with metformin in patients with hereditary leiomyomatosis-related renal cell carcinoma (HLRCC…

• CLINICAL_TRIALS trial_result · 2020-07-10
  Clinical Trial Update: Savolitinib vs. Sunitinib in MET-driven PRCC. [Phase 3]

  A Phase 3 trial comparing savolitinib to sunitinib in MET-driven papillary renal cell carcinoma has posted results and is not currently recr…

• CLINICAL_TRIALS trial_result · 2020-04-08
  Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer [Phase 2]

  Phase 2 trial results for Pazopanib hydrochloride in metastatic or recurrent kidney cancers have been posted after the study completed, incl…

• CLINICAL_TRIALS trial_result · 2017-12-11
  Clinical Trial Update: A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC) [Phase 2]

  Phase II clinical trial results update for GSK1363089 (XL880) in patients with papillary renal cell carcinoma.

• CLINICAL_TRIALS trial_result · 2017-10-12
  Clinical Trial Update: A Phase II Trial to Evaluate the Efficacy of AZD6094 (HMPL-504) in Patients With Papillary Renal Cell Carcinoma (PRCC) [Phase 2]

  Phase II trial evaluating AZD6094 (HMPL-504) in papillary renal cell carcinoma has completed with results posted in 2017.

• CLINICAL_TRIALS trial_result · 2017-06-14
  Clinical Trial Update: Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors [Phase 2]

  Phase 2 clinical trial evaluating combination chemotherapy, radiation therapy, and/or surgery for high-risk pediatric kidney tumors; results…

• CLINICAL_TRIALS trial_result · 2015-11-26
  Clinical Trial Update: RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe [Phase 2]

  Phase 2 trial RAPTOR evaluated RAD001 (everolimus) as monotherapy for advanced papillary renal cell carcinoma; the study is completed with r…

• CLINICAL_TRIALS trial_result · 2013-07-02
  Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]

  Phase 2 clinical trial evaluating sorafenib in combination with interferon alfa-2b for locally advanced or metastatic renal cell carcinoma; …

• CLINICAL_TRIALS trial_result · 2013-06-28
  Clinical Trial Update: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]

  A Phase 1/Phase 2 trial evaluating the combination of sorafenib tosylate and bevacizumab in advanced renal cell carcinoma, with results post…

• CLINICAL_TRIALS trial_result · 2013-02-28
  Clinical Trial Update: Erlotinib in Treating Patients With Locally Advanced or Metastatic Papillary Renal Cell Cancer [Phase 2]

  A Phase 2 trial evaluating erlotinib for locally advanced or metastatic papillary renal cell carcinoma has completed.